Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.03.16.532913

ALaSCA: A novel in silico simulation platform to untangle biological pathway mechanisms, with a case study in Type 1 Diabetes progression

Abstract

IntroductionThe analysis of signaling pathways is a cornerstone in clarifying the biological mechanisms involved in complex genetic disorders. These pathways have intricate topologies, and the existing methods that are used for the interpretation of these pathways, remain limited. We have therefore developed the Adaptable Large-Scale Causal Analysis (ALaSCA) computational platform, which uses causal analysis and counterfactual simulation techniques. ALaSCA offers the ability to simulate the outcome of a number of different hypotheses to gain insight into the complex dynamics of biological mechanisms prior to, or even without, wet lab experimentation. ALaSCA is offered as a proprietary Python library for bioinformaticians and data scientists to use in their life sciences workflows. Here we demonstrate the ability of ALaSCA to untangle the pivots and redundancies within biological pathways of various drivers of a specific phenotypic process. This is achieved by studying a major disease of global relevance, namely Type 1 Diabetes (T1D), and quantifying causal relationships between antioxidant proteins and T1D progression. ALaSCA is also benchmarked against standard associative analysis methods. MethodsWe use our in silico simulation platform, ALaSCA, to apply both a number of machine learning (ML) and data imputation techniques, and perform causal inference and counterfactual simulation. ALaSCA uses standard ML and causal analysis libraries as well as custom code developed for data imputation and counterfactual simulation. Counterfactual simulation is a method for simulating potential or hypothetical model outcomes in the field of causal analysis (Glymour, Pearl and Jewell, 2016). We apply ALaSCA to T1D by using proteomic data from Liu et al. (2018), as the patients were selected based on the presence of T1D susceptible HLA (human leukocyte antigen)-DR/DQ alleles through genotyping at birth and followed prospectively. The genetic cause of T1D in this cohort is therefore known and the mechanism and proteins through which it causes T1D are well-characterized. This biological mechanism was converted into a directed acyclic graph (DAG) for the subsequent causal analyses. The dataset was used to benchmark the causal inference and counterfactual simulation capabilities of ALaSCA. Results and discussionAfter data imputation of the Liu, et al. (2018) dataset, causal inference and counterfactual simulation were completed. The causal inference output of the HLA, antioxidant, and non-causal proteins showed that the HLA proteins had the overall strongest causal effects on T1D, with antioxidant proteins having the overall second largest causal effects on T1D. The non-causal proteins showed negligibly small effects on T1D in comparison with the HLA and antioxidant proteins. With counterfactual simulation we were able to replicate evidence for and gain understanding into the protective effect that antioxidant proteins, specifically Superoxide dismutase 1 (SOD1), have in T1D, a trend which is seen in literature. We were also able to replicate an unusual case from literature where antioxidant proteins, specifically Catalase, do not have a protective effect on T1D. ConclusionBy analyzing the disease mechanism, with the inferred causal effects and counterfactual simulation, we identified the upstream HLA proteins, specifically the DR alpha chain and DR beta 4 chain proteins as causes of the protective effect of the antioxidant proteins on T1D. In contrast, through counterfactual simulation of the unusual case, in which the DR alpha chain and DR beta 4 chain proteins are not present in the model, we saw that the adverse effect which the antioxidant proteins have on T1D is due to the HLA protein, DQ beta 1 chain, and not the antioxidant proteins themselves. Future work would entail the application of the ALaSCA platform on various other diseases, and to integrate it into wet lab experimental design in a number of different biological study areas and topics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Louw, C., Truter, N., Bergh, W., Van den Heever, M., Horn, S., Oudrhiri, R., Van Niekerk, D. D., Loos, B., Singh, R.. 2023-03-20. ALaSCA: A novel in silico simulation platform to untangle biological pathway mechanisms, with a case study in Type 1 Diabetes progression. https://doi.org/10.1101/2023.03.16.532913

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

deepTools4: Faster, Scalable, and Modernized Genomic Data Analysis

The deepTools suite is widely used for quality control, summarization, and visualization of high-throughput sequencing data. However, as genomic datasets grow in scale and depth, existing tools often become computational bottlenecks. We present deepTools4, a modernized framework designed for high performance, scalability, and enhanced usability, while maintaining seamless integration with the Galaxy platform. Core functionality has been rewritten and thoroughly benchmarked, achieving substantial computational speed-ups. Visualization tools have been modernized to provide more intuitive, high-quality graphical outputs. In addition, our testing framework has been expanded to facilitate continuous development and ensure robustness. We demonstrate the utility of deepTools4 across diverse epigenomics and transcriptomics datasets, highlighting its ability to summarize genome-wide signals, apply a wide range of common normalization methods, and visualize enrichment patterns. The enhanced deepTools4 framework delivers a faster, more scalable solution for reproducible genome-wide analysis and interpretation across many sequencing modalities. Availability: https://github.com/deeptools/deepTools/

bioinformatics↗

Reproducibility and cross-dataset concordance of drug-induced transcriptional responses

Drug-perturbation transcriptomic resources are expanding, but the reproducibility and cross-source consistency of the responses they measure remain critical to their use. We compared six resources using independent replicates, matched-drug analyses, and response decomposition. High agreement in treated expression did not translate into equally repeatable drug-induced changes. Cross-source response concordance was generally limited, including under matched cell and treatment conditions, although some comparisons retained drug-specific information. In Tahoe, a control-expression-only baseline left substantial drug-specific variation unresolved. Measured drug main effects - the average responses across cell lines - provided information for predicting cell-specific interactions, with this relationship retained in a cross-plate validation. Exploratory analyses of structure, target, and external-response representations identified modest signals in selected pipelines. Together, these analyses characterize the reliability and transferability of current perturbation resources and identify prediction of drug main effects as a key bottleneck in the framework examined, motivating shared reference measurements and better recovery of drug-specific responses.

bioinformatics↗

Propensity-Adjusted AUC under Nuisance-Model Misspecification

Propensity adjustment compares medical-image detector scores within groups with similar measured properties, such as stain or focus. We examine its sensitivity to the nuisance model that forms those groups. Under Gaussian latent-index assumptions and exact linear-index strata, a closed-form correlation gives an exact boundary for adjusted AUC to fall below one half. Quadrature matches 36 simulation cells within 0.008. Inflation and attenuation relative to correct adjustment are empirical findings, not general ordering results. An overlap screen and a self-stratified control introduced for this study miss 140 of 141 simulated cells with absolute error above 0.05: checking the fitted propensity cannot certify completeness of the adjustment set. On real pathology corpora, logistic and boosted-tree models using the same 16 features disagree. Among splits where both pass both checks, mean adjusted-AUC gaps are 0.057 on acid-fast bacilli (AFB), 0.048 on Kaggle, and 0.049 on PCam, over three, five, and three splits respectively. These gaps measure model sensitivity; neither estimate is known to be correct. A controlled colour shift moves adjusted AUC relative to model-specific references in the predicted direction in 78 of 80 label-dependent cells. Broader balance and label-fit diagnostics favour trees without certifying their adjusted AUC. We recommend reporting sensitivity across nuisance models alongside these diagnostics. Reversal relative to known truth occurs in constructed stress tests; its frequency in practice remains unknown.

bioinformatics↗